A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
Caltech just manufactured a wearable sweat sensor that “inkjet prints” biomarkers to better monitor the human body.
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
Demystifying the ROI of Clinical AI
“Inclusive excellence” program had committed $60 million to 104 institutions
The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.
Firdausi Qadri hopes widespread use of cheap oral cholera vaccines can help vanquish an old scourge
Despite staffing shortages and chaotic work environments, market researchers said increased clinician EHR satisfaction, improved payer/provider relationships and progress on SDOH are advancing
La Pine Community Health Center has laid off 11% of its staff of 90, pending more details about a freeze on federal funding, but said…
Humpback whale song is a culturally transmitted behavior. Human language, which is also culturally transmitted, has statistically coherent parts whose frequency distribution follows a power…
Nature Immunology – Here the authors identify a nuclear short form of IL-18 in cancer cells that can enhance NK cell activation to promote tumor…